Valdoxan or Agomelatine: A new depression treatment About 40-50% of people taking the current antidepressants, or the SSRIs, stop treatment shortly after starting. This is because that class of medications has certain significant side effects, like nauseua and sexual dysfunction.... (Continue reading)
Abilify: way oversold You probably have seen a TV ad recently for Abilify. I do all the time. It’s terrible. Each time I’m amazed at the audacity of its makers, Bristol-myers Squibb. They’re making a killing off those ads; they... (Continue reading)
At least 1/3 of the time depression doesn’t respond to the first medication tried. If another attempt doesn’t work, it becomes “treatment resistant depression.” If your depression isn’t lifting, here are ten ideas you might want to consider: 1) It... (Continue reading)
Note: This is an editorial Antidepressants – what’s going on? One out of ten Americans are currently on antidepressants. That’s just the beginning. More than 25% of college students at some schools are on them. Everyone is being given them... (Continue reading)